Literature DB >> 16785520

FOXP3+CD4+CD25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism.

Milada Mahic1, Sheraz Yaqub, C Christian Johansson, Kjetil Taskén, Einar M Aandahl.   

Abstract

CD4+CD25+ regulatory T (T(R)) cells suppress effector T cells by partly unknown mechanisms. In this study, we describe a population of human suppressive CD4+CD25+ adaptive T(R) (T(R)(adapt)) cells induced in vitro that express cyclooxygenase 2 (COX-2) and the transcription factor FOXP3. T(R)(adapt) cells produce PGE(2) and suppress effector T cell responses in a manner that is reversed by COX inhibitors and PGE(2) receptor-specific antagonists. In resting CD4+CD25- T cells, treatment with PGE(2) induced FOXP3 expression. Thus, autocrine and paracrine effects of PGE(2) produced by COX-2-positive T(R)(adapt) cells may be responsible for both the FOXP3+ phenotype and the mechanism used by these cells to suppress effector T cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785520     DOI: 10.4049/jimmunol.177.1.246

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  78 in total

Review 1.  Modulation of T cell immune functions by the prostaglandin E(2) - cAMP pathway in chronic inflammatory states.

Authors:  Kristoffer Watten Brudvik; Kjetil Taskén
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2.

Authors:  Liwen Chen; Yibei Zhu; Guangbo Zhang; Chao Gao; Weixue Zhong; Xueguang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

3.  An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses.

Authors:  Frank O Pettersen; Eirik A Torheim; Anders E A Dahm; Ingeborg S Aaberge; Andreas Lind; Malin Holm; Einar M Aandahl; Per M Sandset; Kjetil Taskén; Dag Kvale
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

4.  Ultraviolet B suppresses immunity by inhibiting effector and memory T cells.

Authors:  Sabita Rana; Scott Napier Byrne; Linda Joanne MacDonald; Carling Yan-Yan Chan; Gary Mark Halliday
Journal:  Am J Pathol       Date:  2008-02-21       Impact factor: 4.307

5.  Targeted deletions of cyclooxygenase-2 and atherogenesis in mice.

Authors:  Yiqun Hui; Emanuela Ricciotti; Irene Crichton; Zhou Yu; Dairong Wang; Jane Stubbe; Miao Wang; Ellen Puré; Garret A FitzGerald
Journal:  Circulation       Date:  2010-06-07       Impact factor: 29.690

6.  Effect of Bone Morphogenetic Protein 6 on Immunomodulatory Functions of Salivary Gland-Derived Mesenchymal Stem Cells in Sjögren's Syndrome.

Authors:  Junji Xu; Yingying Su; Lei Hu; Alexander Cain; Yi Gu; Bowen Liu; Ruiqing Wu; Songlin Wang; Hao Wang
Journal:  Stem Cells Dev       Date:  2018-11-15       Impact factor: 3.272

7.  Selective PGE(2) suppression inhibits colon carcinogenesis and modifies local mucosal immunity.

Authors:  Masako Nakanishi; Antoine Menoret; Takuji Tanaka; Shingo Miyamoto; David C Montrose; Anthony T Vella; Daniel W Rosenberg
Journal:  Cancer Prev Res (Phila)       Date:  2011-05-16

Review 8.  Tregs and rethinking cancer immunotherapy.

Authors:  Tyler J Curiel
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 9.  Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology.

Authors:  Hedi Harizi
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

Review 10.  The Microenvironment of Tongue Cancer.

Authors:  Want Tao; Zeng Li-Juan; Li Kan; Li Jing-Yuan; Liu Xiang-Qi; Liang Yu-Jie
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.